Author | Evelyn Cadman

Articles

NDIs for dietary supplements: How to proceed in 2020

February 24, 2020

What have we learned in the past year, and how should industry proceed in 2020?

Which GMPs for the cannabis industry? Pharmaceutical, food, or dietary supplement?

August 26, 2019

Where do hemp and cannabinoid companies fit in the manufacturing standards regimen? This has become the question in the absence of clear FDA guidance and regulations for manufacturing.

Best practices for CBD testing, from industry experts

August 12, 2019

Analytical testing and regulatory experts advise on how to test for CBD quality.

What is CBD’s regulatory status, and how should companies proceed with caution? Leading industry regulatory consultants chime in.

August 05, 2019

The authors write: “It seems that foods and beverages containing CBD are likely to remain high-risk, while dietary supplements would appear to be a slightly lower-risk option for manufacturers or distributors of CBD-containing products.”